Diabetes

Long-acting analog insulin doesn't up AMI risk in T2DM

(HealthDay)—For patients with type 2 diabetes, the risk of acute myocardial infarction (AMI) is not significantly different for long-acting insulin analogs versus other basal insulin therapies, according to a study published ...

Diabetes

CVD risk similar for metformin + insulin or sulfonylureas

(HealthDay)—For patients with type 2 diabetes, the risk of myocardial infarction (MI) or stroke is similar for treatment with insulin or sulfonylureas in combination with metformin, according to a study published online ...

page 3 from 40